Search results for: NHS Expenditure
Filter search results
Patient-reported outcomes measures (PROMs) in Health Economics – an Overview and Key Developments in the Field
30 June 2015
…Excellence (NICE). Since 2009, PROMs data, including the EQ-5D, have been routinely collected across English NHS providers of four key elective interventions. In her presentation, Nancy introduced the use of…
An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies
7 July 2015
…University of Singapore), OHE’s Mike Herdman and colleagues; a paper in Quality of life Research [open access] which assesses the performance of the EQ-VAS in the NHS, authored by…
Future Cases of Dementia among People Born in 2015 & the Dementia Drug Pipeline
6 October 2015
…NHS choices website here. Download the full OHE analysis here. The research on drug development success rates was part of an R&D landscape and pipeline analysis of the…
Valuing Health at the End of Life: A Review of the Empirical Literature
3 November 2015
…the appraisal of life-extending end of life treatments. This includes an option for recommending such treatments for use in the NHS if certain criteria are met, even if their base…
OHE at ISPOR Europe: Milan 2015
1 December 2015
…and advising; academic institutions; and public policy making. This included comments on: his role in reorganising NHS R&D, and in setting up NICE; his theoretical contribution to extra-welfarism, and to…
New Publication: Headroom Approach to Device Development
23 February 2016
…of a pharmaceutical product; these differences have important implications for both the developer and the health care decision-maker tasked with assessing its value to patients and the NHS (Chapman, 2014)….
Just Published: OHE Report on Trends in Scottish Medicines Committee Advice Decisions
25 February 2016
…between pharmaceutical companies and NHS Scotland, usually to offer a medicine at a reduced cost, with the intention to encourage SMC to recommend use. We found that there has been…
OHE Lunchtime Seminar and Webinar on 21 September 2016: Health Economic Evaluation throughout the Ages
2 August 2016
…Mushkin. Proposals for the evaluation of pharmaceuticals and other aspects of the NHS in the United Kingdom that arose from the late 1950s. Prof Philip Clarke heads the Health…
OHE at EuHEA 2016: Opportunity Costs, Value Based Pricing, Economies of Scope and Quality of Life
17 August 2016
…qualitative study from Wales by Sarah Karlsberg Schaffer Sarah presented the results of a recently-published paper investigating what, in practice, is foregone in the NHS when new cost-increasing technologies are recommended…